VOYA Investment Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4,774
| Closed | -$236K | – | 2918 |
|
|
2022
Q1 | $236K | Buy |
4,774
+297
| +7% | +$14.7K | ﹤0.01% | 2288 |
|
|
2021
Q4 | $228K | Buy |
4,477
+192
| +4% | +$9.78K | ﹤0.01% | 2433 |
|
|
2021
Q3 | $239K | Buy |
+4,285
| New | +$239K | ﹤0.01% | 2475 |
|
|
2021
Q2 | – | Sell |
-8,139
| Closed | -$340K | – | 2917 |
|
|
2021
Q1 | $340K | Buy |
8,139
+868
| +12% | +$36.3K | ﹤0.01% | 2256 |
|
|
2020
Q4 | $339K | Buy |
7,271
+44
| +0.6% | +$2.05K | ﹤0.01% | 2133 |
|
|
2020
Q3 | $307K | Sell |
7,227
-71
| -1% | -$3.02K | ﹤0.01% | 1938 |
|
|
2020
Q2 | $350K | Sell |
7,298
-968
| -12% | -$46.4K | ﹤0.01% | 1883 |
|
|
2020
Q1 | $380K | Sell |
8,266
-5,171
| -38% | -$238K | ﹤0.01% | 1793 |
|
|
2019
Q4 | $807K | Buy |
13,437
+135
| +1% | +$8.11K | ﹤0.01% | 1586 |
|
|
2019
Q3 | $752K | Buy |
13,302
+4,477
| +51% | +$253K | ﹤0.01% | 1501 |
|
|
2019
Q2 | $491K | Buy |
8,825
+4,547
| +106% | +$253K | ﹤0.01% | 1791 |
|
|
2019
Q1 | $216K | Buy |
+4,278
| New | +$216K | ﹤0.01% | 2234 |
|
|
2018
Q4 | – | Sell |
-4,030
| Closed | -$279K | – | 2589 |
|
|
2018
Q3 | $279K | Hold |
4,030
| – | – | ﹤0.01% | 2180 |
|
|
2018
Q2 | $305K | Buy |
+4,030
| New | +$305K | ﹤0.01% | 2130 |
|
|
2017
Q4 | – | Sell |
-4,204
| Closed | -$251K | – | 2607 |
|
|
2017
Q3 | $251K | Hold |
4,204
| – | – | ﹤0.01% | 2263 |
|
|
2017
Q2 | $332K | Buy |
4,204
+675
| +19% | +$53.3K | ﹤0.01% | 2089 |
|
|
2017
Q1 | $293K | Hold |
3,529
| – | – | ﹤0.01% | 2064 |
|
|
2016
Q4 | $280K | Sell |
3,529
-593
| -14% | -$47.1K | ﹤0.01% | 2099 |
|
|
2016
Q3 | $289 | Buy |
+4,122
| New | +$289 | ﹤0.01% | 2061 |
|
|
2016
Q1 | – | Sell |
-3,568
| Closed | -$316K | – | 2532 |
|
|
2015
Q4 | $316K | Hold |
3,568
| – | – | ﹤0.01% | 2028 |
|
|
2015
Q3 | $264K | Sell |
3,568
-603
| -14% | -$44.6K | ﹤0.01% | 2113 |
|
|
2015
Q2 | $337K | Buy |
+4,171
| New | +$337K | ﹤0.01% | 2183 |
|